- Funding Received
- $794 Thousand in 6 Rounds from 6 Investors
- Most Recent Funding
- $30 Thousand Grant on January 1, 2014
- October 7, 2011
- Providence, RI
- 121nexus offers cloud-based track and trace solutions, integrated with product packaging, for biomedical manufacturers.
- Albert Ho, Foster Sayers
- Politics, Technology, Medical Devices, Pharmaceuticals, Personalization, Software
121nexus deploys cloud-based track & trace solutions for biomedical manufacturers. A recent report prepared by McKinsey & Co estimates that the cost of medical errors introduced by inadequate track & trace on medical devices is estimated to be between $18 and $115 billion annually. In response to the need in the industry for such a track & trace solution, 121nexus developed MDDTrack™, which is a cloud-based software solution for manufacturers to enhance recall management and post-market surveillance in the medical devices and diagnostics industry.
121nexus' technology solves a problem so critical to public health that it was awarded a National Science Foundation grant to accelerate commercialization of this unique approach to biomedical track & trace. The core technology has been claimed in US Patent 8,533,075, US Patent applications 13/792,651 and 13/925,039, and International application PCT/US14/10293.
Current Team (2)Update
Funding Rounds (6) - $794kUpdate
121 Campaign™ was launched in 2012
PharTrack™ is a cloud-based solution for drug product safety, security, and education. The...
IFUTrack™ is our solution for publishing electronic instructions for use in compliance with the...
MDDTrack™ is a patented technology for Unique Device Identification (UDI) that provides complete...
Boston, MA 02127
Providence, RI 02903